<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Cytotechnology</journal-id><journal-id journal-id-type="iso-abbrev">Cytotechnology</journal-id><journal-title-group><journal-title>Cytotechnology</journal-title></journal-title-group><issn pub-type="ppub">0920-9069</issn><issn pub-type="epub">1573-0778</issn><publisher><publisher-name>Springer Netherlands</publisher-name><publisher-loc>Dordrecht</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40012927</article-id><article-id pub-id-type="pmc">PMC11861467</article-id><article-id pub-id-type="publisher-id">729</article-id><article-id pub-id-type="doi">10.1007/s10616-025-00729-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Fermented plant product (FPP) suppresses immediate hypersensitivity reactions with impaired high-affinity IgE receptor (Fc&#x003b5;RI) signaling</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Kodama</surname><given-names>Tomoki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Yokoyama</surname><given-names>Ayana</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Nishioka</surname><given-names>Yuki</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Kawasaki</surname><given-names>Riku</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Teshima</surname><given-names>Aiko</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Maeda</surname><given-names>Akira</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Hojo</surname><given-names>Ayano</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Suizu</surname><given-names>Takumi</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Torii</surname><given-names>Hideto</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fujioka</surname><given-names>Kotaro</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Kishida</surname><given-names>Shinsuke</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Fujimura</surname><given-names>Takashi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Arakawa</surname><given-names>Kenji</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Ikeda</surname><given-names>Atsushi</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Kawamoto</surname><given-names>Seiji</given-names></name><address><email>skawa@hiroshima-u.ac.jp</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03t78wx29</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution>Program of Biotechnology, Graduate School of Integrated Sciences for Life, </institution><institution>Hiroshima University, </institution></institution-wrap>1-3-1 Kagamiyama, Higashi-Hiroshima, 739-8530 Japan </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03t78wx29</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution>Hiroshima Research Center for Healthy Aging (HiHA), </institution><institution>Hiroshima University, </institution></institution-wrap>Higashi-Hiroshima, Japan </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03t78wx29</institution-id><institution-id institution-id-type="GRID">grid.257022.0</institution-id><institution-id institution-id-type="ISNI">0000 0000 8711 3200</institution-id><institution>Program of Applied Chemistry, Graduate School of Advanced Science and Engineering, </institution><institution>Hiroshima University, </institution></institution-wrap>Higashi-Hiroshima, Japan </aff><aff id="Aff4"><label>4</label>Manda Fermentation Co. Ltd, Onomichi, Japan </aff></contrib-group><pub-date pub-type="epub"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2025</year></pub-date><volume>77</volume><issue>2</issue><elocation-id>69</elocation-id><history><date date-type="received"><day>10</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>13</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Fermented plant product (FPP) is a dietary supplement made by fermentation and aging of a variety of plants, including fruits, vegetables, and grains. A previous study has shown that oral FPP supplementation prevents the development of allergic rhinitis-like nasal symptoms in a murine model of Japanese cedar pollinosis without affecting systemic immune response. However,&#x03000;the mode of action by which FPP exerts an anti-allergic effect remains to be elucidated. Here, we show that FPP acts on mast cells to suppress immediate hypersensitivity reactions in vitro as well as in vivo. We found that stimulation with FPP potently suppressed IgE antibody-mediated degranulation of RBL-2H3 rat basophilic leukemia cells. We also found that oral feeding with FPP significantly suppressed passive cutaneous anaphylaxis (PCA), an in vivo model of IgE- and mast cell-mediated hypersensitivity reactions. Mechanistic analysis revealed that FPP extensively suppressed the high-affinity IgE receptor (Fc&#x003b5;RI) signaling pathway, in which FPP not only inhibited intracellular Ca<sup>2+</sup> influx upon Fc&#x003b5;RI ligation but also negatively regulated another Ca<sup>2+</sup>-independent Fc&#x003b5;RI signaling pathway leading to granule translocation through microtubule formation. These results suggest that FPP fulfills its anti-allergic activity by acting on the IgE-mast cell axis to suppress immediate hypersensitivity reactions.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Allergy</kwd><kwd>Fermented plant product (FPP)</kwd><kwd>IgE</kwd><kwd>Mast cells</kwd><kwd>Passive cutaneous anaphylaxis (PCA)</kwd></kwd-group><funding-group><award-group><funding-source><institution>Manda Fermentation Co., Ltd.</institution></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution>Hiroshima University</institution></funding-source></award-group><open-access><p>Open Access funding provided by Hiroshima University.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature B.V. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par24">The increased prevalence of allergy is a worldwide problem (Weinberg <xref ref-type="bibr" rid="CR37">2011</xref>). Typical type I allergy is triggered upon allergen-triggered cross-linking of IgE antibodies that have been pre-sensitized on mast cells (Rajan <xref ref-type="bibr" rid="CR32">2003</xref>). This mast cell surface IgE cross-linking induces the release of histamine and other proinflammatory mediators, which in turn leads to immediate hypersensitivity reactions causing atopic symptoms, including asthma, rhinitis, eczema, and food anaphylaxis (Rajan <xref ref-type="bibr" rid="CR32">2003</xref>) (Zhang et al. <xref ref-type="bibr" rid="CR39">2023</xref>). Symptomatic anti-allergic drugs are designed to antagonize those mediator molecules for relief of the allergic conditions, but current drugs still have side effects reducing the quality of life (Zhang et al. <xref ref-type="bibr" rid="CR39">2023</xref>) (Kay <xref ref-type="bibr" rid="CR22">2000</xref>) (Malone <xref ref-type="bibr" rid="CR24">2017</xref>), and no curative effect is obtained by such symptomatic medications. Allergen-specific immunotherapy (AIT) represents another clinical option for allergy with the hope of curative outcomes, although current therapies still have problems, such as the need for long-term medication, varied therapeutic effects, and the lack of precise therapeutic mechanisms (Akdis and Akdis <xref ref-type="bibr" rid="CR1">2011</xref>) (Fujimura and Kawamoto <xref ref-type="bibr" rid="CR9">2015</xref>).</p><p id="Par25">In such situations, there is a growing interest in the potential of functional foods with anti-allergic effects as alternatives to allergy medications, aiming for symptom alleviation and preventive benefits (Fujimura et al. <xref ref-type="bibr" rid="CR11">2023</xref>). One such example of a functional foodstuff is an edible herb with anti-allergic potency. One of those examples is <italic>Perilla frutescens</italic>, an anti-inflammatory medicinal herb traditionally consumed in East Asian countries (Kamei et al. <xref ref-type="bibr" rid="CR14">2017</xref>) (Wu et al. <xref ref-type="bibr" rid="CR38">2023</xref>), and responsible anti-allergic compounds have been identified (Kamei et al. <xref ref-type="bibr" rid="CR14">2017</xref>) (Wu et al. <xref ref-type="bibr" rid="CR38">2023</xref>) (Oh et al. <xref ref-type="bibr" rid="CR31">2011</xref>).</p><p id="Par26">In addition to those medicinal plants, fermented foods are also known to provide health benefits, including anti-inflammatory effects (Shahbazi et al. <xref ref-type="bibr" rid="CR34">2021</xref>) (Sanlier et al. <xref ref-type="bibr" rid="CR33">2019</xref>) (Baruah et al. <xref ref-type="bibr" rid="CR4">2022</xref>). Fermented plant product (FPP) is a healthy supplemental food obtained through long-term fermentation and aging (over 3&#x000a0;years) of a variety of fruits, vegetables, grains, and algae (Kawai <xref ref-type="bibr" rid="CR16">1997</xref>) (Kawai et al. <xref ref-type="bibr" rid="CR17">1998</xref>) (Marotta et al. <xref ref-type="bibr" rid="CR25">2009</xref>) (Ashida <xref ref-type="bibr" rid="CR2">2005</xref>) (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>). Several health-promoting effects of FPP have been reported in various pathological conditions, such as the alleviation of stomach ulcers (Kawai <xref ref-type="bibr" rid="CR16">1997</xref>), inhibition of lipid peroxidation (Kawai et al. <xref ref-type="bibr" rid="CR17">1998</xref>), anti-cancer effect (Marotta et al. <xref ref-type="bibr" rid="CR25">2009</xref>), and activation of innate immunity (Ashida <xref ref-type="bibr" rid="CR2">2005</xref>).</p><p id="Par27">Our research group has shown that oral feeding with FPP prevents the development of allergic rhinitis-like nasal symptoms in a murine model of seasonal pollinosis without affecting allergen-specific adaptive immunity, including T helper type 2 (Th2) response and IgE antibody production (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>). In this system, the oral FPP supplementation tends to decrease the serum level of the in vivo mast cell activation marker, mouse mast cell protease-1 (mMCP-1) (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>), implicating that FPP may act on mast cells to fulfill its anti-allergic effect. Based on this assumption, here we tested whether FPP showed any inhibitory activity on the mast cell-mediated allergic response and further investigated the underlying mechanisms. We show that FPP acts directly on mast cells to suppress IgE-mediated type I hypersensitivity reactions in vitro as well as in vivo. We also provide mechanistic evidence that FPP negatively regulates Fc&#x003b5;RI signaling pathway to suppress immediate hypersensitivity reactions.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Fermented plant product (FPP) and preparation of its water-soluble fraction</title><p id="Par28">Fermented plant product (FPP, MANDA<sup>&#x000ae;</sup>) was manufactured and provided by Manda Fermentation Co., Ltd. (Onomichi, Japan). For in vitro experiments, FPP was dissolved in a Modified Tyrode&#x02019;s buffer [MT buffer; 135&#x000a0;mM NaCl, 5&#x000a0;mM KCl, 2.7&#x000a0;mM CaCl<sub>2</sub>, 1.0&#x000a0;mM MgCl<sub>2</sub>, 5.6&#x000a0;mM D (+)-glucose, and 0.05% bovine serum albumin (BSA) in 20&#x000a0;mM HEPES, pH 7.4], and centrifuged at 15,000&#x02009;&#x000d7;&#x02009;<italic>g</italic> for 10&#x000a0;min. The resultant water-soluble FPP sample was then sterilized using a DISMIC 0.2&#x000a0;&#x003bc;m filter (ADVANTEC, Tokyo, Japan), and used as for in vitro experiments.</p></sec><sec id="Sec4"><title>Antibodies</title><p id="Par29">All antibody reagents were purchased from Cell Signaling Technology (Danvers, MA, USA) as follows; anti-Syk monoclonal antibody (mAb, #13198, 1:1250 dilution), anti-phospho-Syk (pSyk, pTyr 525/526) mAb (#2710, 1:1000), anti-PLC&#x003b3;1 mAb (#5690, 1:1000), anti-phospho-PLC&#x003b3;1 (pPLC&#x003b3;1, pTyr 783) mAb (#2821, 1:1000), anti-PI3 kinase (PI3K) p85 mAb (#4257, 1:1000), anti-phospho-PI3K p85 (pTyr 458)/p55 (pTyr199) antibody (Ab) (#4228, 1:1000), anti-Akt Ab (#9272, 1:2500), anti-phospho-Akt (pAkt, pSer 473) Ab (#9271, 1:1000), anti-GSK3&#x003b2; mAb (#12456, 1:5000), anti-phospho-GSK3&#x003b2; (pGSK3&#x003b2;, pSer 9) mAb (#5558, 1:2500), horseradish peroxidase (HRP)-conjugated anti-rabbit IgG Ab (#7074, 1:2500), and Alexa Fluor<sup>&#x000ae;</sup> 488-conjugated anti-&#x003b1;-tubulin mAb (#5063, 1:200).</p></sec><sec id="Sec5"><title>Cell culture</title><p id="Par30">RBL-2H3 rat basophilic leukemia cells were obtained from the Riken Bioresource Center (RIKEN BRC, Ibaraki, Japan), and cultured in minimum essential medium (MEM; Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO, USA) and 100 units/ml penicillin&#x02013;streptomycin (Thermo Fisher Scientific) in humidified 5% CO<sub>2</sub> atmosphere at 37&#x000a0;&#x000b0;C.</p></sec><sec id="Sec6"><title>&#x003b2;-hexosaminidase release assay</title><p id="Par31">RBL-2H3 cells were seeded in 96-well plates at a density of 6&#x02009;&#x000d7;&#x02009;10<sup>4</sup> cells/well, and pre-cultured for 8&#x000a0;h in humidified 5% CO<sub>2</sub> atmosphere at 37&#x000a0;&#x000b0;C. Cells were sensitized with 50&#x000a0;ng/ml anti-DNP IgE mAb (YAMASA Co., Ltd., Chiba, Japan) diluted in 10% FBS-MEM medium (200&#x000a0;&#x000b5;l/well) and incubated for 16&#x000a0;h. Unsensitized cells were used as a negative control. The IgE-sensitized cells were washed with phosphate-buffered saline (PBS), and treated with FPP (7.5&#x02013;15&#x000a0;mg/ml) or 500&#x000a0;&#x003bc;M ketotifen fumarate (KF; a positive control inhibitor of degranulation, FUJIFILM Wako Pure Chemical, Osaka, Japan) diluted in MT buffer (vehicle), and incubated for 30&#x000a0;min. Cells were then stimulated with 0.5&#x000a0;&#x003bc;g/ml DNP-BSA antigen (Ag) at 37&#x000a0;&#x000b0;C for 30&#x000a0;min to induce degranulation, and the reaction was stopped for 10&#x000a0;min incubation at 4&#x000a0;&#x000b0;C. For &#x003b2;-hexosaminidase assay, culture supernatant (50&#x000a0;&#x000b5;l/well in a 96-well microtiter plate) was mixed with 5&#x000a0;mM <italic>N</italic>-acetyl-&#x003b2;-D-glucosaminide substrate, and incubated at 37&#x000a0;&#x000b0;C for 30&#x000a0;min, followed by addition of 50&#x000a0;&#x003bc;l glycine buffer (pH 10.4) to stop the enzymatic reaction. The absorbance at 405&#x000a0;nm was then measured by Wallac 1420 ARVOsx Multilabel Counter (PerkinElmer Life Sciences, Waltham, MA, USA), and &#x003b2;-hexosaminidase release (%) was calculated as following formula; &#x003b2;-hexosaminidase release (%)&#x02009;=&#x02009;100 x [(A<sub>supernatant</sub>)-(A<sub>blank of FPP</sub>)] / [ (A<sub>cell lysate</sub>)-(A<sub>blank of cell lysate</sub>)], in which &#x0201c;A&#x0201d; is the absorbance of each well.</p></sec><sec id="Sec7"><title>Cell viability assay</title><p id="Par32">Cell viability was analyzed by trypan blue dye exclusion assay. RBL-2H3 cells were seeded in 24 well plates at a density of 1.5&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/well and sensitized with anti-DNP IgE mAb as described above. Cells were then treated with serial concentrations of FPP or 500&#x000a0;&#x003bc;M KF for 30&#x000a0;min, followed by stimulation with Ag for 30&#x000a0;min. After washing with PBS and trypsinization, cell suspension was stained with 0.4% trypan blue dye solution (Thermo Fisher Scientific). The cell viability ratio was calculated as follows; Cell viability (%)&#x02009;=&#x02009;S/T&#x02009;&#x000d7;&#x02009;100, in which S is the number of unstained cells and T is the total cell number.</p></sec><sec id="Sec8"><title>Passive cutaneous anaphylaxis (PCA)</title><p id="Par33">PCA was performed using the previously described method with minor modifications (Kawasaki et al. <xref ref-type="bibr" rid="CR21">2023</xref>). Briefly, five-week-old female BALB/c mice (Jackson Laboratory Japan Inc., Kanagawa, Japan) maintained under specific pathogen-free conditions were fed AIN-93N diet containing 5% (w/w) FPP (manufactured by Oriental Yeast Co., Ltd., Tokyo, Japan) or control AIN-93N diet (Oriental Yeast) for 64&#x000a0;days. On day 63, anti-DNP IgE (150&#x000a0;ng, in 10&#x000a0;&#x003bc;l PBS) or PBS (vehicle control) was intradermally injected into the right or left ear of each mouse, respectively. After 24&#x000a0;h, 200&#x000a0;&#x003bc;g DNP-human serum albumin (HSA, Sigma-Aldrich) with 1% Evans blue (EB) dye solution (100&#x000a0;&#x003bc;l) was intravenously injected into their tail vein. After 30&#x000a0;min, the PCA reaction was evaluated based on the amount of auricular extravasation of EB dye. For quantification, the EB dye was extracted by 24&#x000a0;h incubation of ear samples with formamide at 63&#x000a0;&#x000b0;C, and their amounts were quantified by spectrophotometry upon measurement of absorbance at 595&#x000a0;nm. All animal experiments were carried out using protocols (protocol number: C20-2&#x02013;10) approved by the Committee on Animal Experimentation of Hiroshima University, Japan.</p></sec><sec id="Sec9"><title>Measurement of intracellular Ca<sup>2+</sup> influx</title><p id="Par34">Measurement of intracellular Ca<sup>2+</sup> influx was performed using the previously described methods (Kamei et al. <xref ref-type="bibr" rid="CR14">2017</xref>) (Karakus et al. <xref ref-type="bibr" rid="CR15">2020</xref>) (Chen et al. <xref ref-type="bibr" rid="CR7">2017</xref>) with minor modifications. For the measurement of IgE-dependent Ca<sup>2+</sup> influx, anti-DNP IgE mAb-sensitized RBL-2H3 cells were loaded with 5&#x000a0;&#x003bc;g/ml Fluo 4-AM in a loading buffer [1.25&#x000a0;mM probenecid, 0.04% Pluronic&#x000ae;F127 (Dojin Chemical Laboratories, Kumamoto) in MT buffer] at 37&#x000a0;&#x000b0;C for 1&#x000a0;h. After washing with PBS, the cells were treated with FPP (12.5&#x02013;15&#x000a0;mg/ml) at 37&#x000a0;&#x000b0;C for 30&#x000a0;min, followed by stimulation with 0.5&#x000a0;&#x003bc;g/ml DNP-BSA. Changes in fluorescence intensity were monitored with Wallac 1420 ARVOsx Multilabel Counter (PerkinElmer Life Sciences). For the measurement of store-operated Ca<sup>2+</sup> entry (SOCE), Fluo 4-AM-loaded RBL-2H3 cells were stimulated with 0.9&#x000a0;&#x003bc;M ionomycin (Nacalai tesque, Kyoto, Japan) and fluorescence was detected as described above. Alternatively, the Fluo 4-labelled RBL-2H3 cells were pre-chelated for 100&#x000a0;s with MT buffer containing 0.5&#x000a0;mM ethylene glycol tetraacetic acid (EGTA, Dojin Chemical Laboratories), and then stimulated with 10&#x000a0;&#x003bc;M thapsigargin (TG, FUJIFILM Wako Pure Chemical) for 200&#x000a0;s to induce the primary Ca<sup>2+</sup> release from endoplasmic reticulum (ER). Then the secondary SOCE was induced upon stimulation with MT buffer supplemented with 2.7&#x000a0;mM CaCl<sub>2</sub> and 10&#x000a0;&#x003bc;M TG in the presence of FPP.</p></sec><sec id="Sec10"><title>Immunofluorescence staining and confocal microscopic analysis</title><p id="Par35">Microtubule formation was visualized by immunofluorescence microscopy by the previously described methods (Nugrahini et al. <xref ref-type="bibr" rid="CR29">2020</xref>). Briefly, RBL-2H3 cells seeded and pre-cultured in a multi-well bottom dish (#D141400, MATSUNAMI, Osaka, Japan) were sensitized with anti-DNP IgE mAb. Then the cells were treated with FPP or 3&#x000a0;&#x003bc;M nocodazole (a positive control reagent as a microtubule formation inhibitor) for 30&#x000a0;min at 37&#x000a0;&#x000b0;C, followed by 5&#x000a0;min stimulation with 0.5&#x000a0;&#x003bc;g/ml DNP-BSA. After washing with PBS, cells were fixed with 4% formaldehyde/PBS at room temperature for 15&#x000a0;min. Then, the cells were permeabilized with 0.2% Triton X-100/PBS at room temperature for 15&#x000a0;min. For antibody staining, cells were blocked with 5% BSA/PBS for 1&#x000a0;h and stained with Alexa Fluor&#x000ae; 488 conjugated anti-&#x003b1;-Tubulin mAb at 4&#x000a0;&#x000b0;C overnight. After washing and nuclear staining with 0.1&#x000a0;&#x003bc;g/ml DAPI/PBS at room temperature for 30&#x000a0;min, the cells were subjected to anti-&#x003b1;-tubulin immunofluorescence imaging by a LSM700 confocal microscope (Zeiss, Oberkochen, Germany).</p></sec><sec id="Sec11"><title>Immunoblot analysis</title><p id="Par36">Immunoblot analysis was performed as described (Kamei et al. <xref ref-type="bibr" rid="CR14">2017</xref>). Briefly, anti-DNP IgE-sensitized RBL-2H3 cells were stimulated with 0.5&#x000a0;&#x003bc;g/ml DNP-BSA/MT buffer at 37&#x000a0;&#x000b0;C, and cell samples were collected at 1, 2, 5, and 10&#x000a0;min. The cells were lysed in RIPA buffer (Nacalai tesque) supplemented with phosphatase inhibitor cocktail (Nacalai tesque) upon incubation at 4&#x000a0;&#x000b0;C for 30&#x000a0;min. Soluble cell lysates were obtained via centrifugation at 14,000&#x02009;&#x000d7;&#x02009;<italic>g</italic> for 15&#x000a0;min. The protein concentration of each cell lysate was determined using the Bio-Rad Protein Assay Reagent (Bio-Rad Laboratories, CA, USA) for equalized protein loading. Resultant protein samples were resolved by sodium dodecyl sulfate&#x02013;polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions, and then electronically transferred onto polyvinylidene fluoride (PVDF) membranes (Immobilon-P; Merck Millipore, Burlington, MA, USA) using the WSE-4040 apparatus (ATTO, Tokyo, Japan). After washing (10&#x000a0;min wash for three times) with tris-buffered saline (150&#x000a0;mM NaCl/50&#x000a0;mM Tris&#x02013;HCl, pH7.4) supplemented with 0.1% Tween-20 (TBST), the membranes were blocked with 5% skim milk/TBST or 5% BSA/TBST at room temperature for 1&#x000a0;h, followed by overnight incubation with primary antibodies at 4&#x000a0;&#x000b0;C. After washing, membranes were incubated with HRP-conjugated secondary antibodies at room temperature for 1&#x000a0;h. After the final washing, protein bands were visualized using the ECL Prime Western Blotting Detection System (Cytiva, Marlborough, MA, USA). Phosphorylated protein signals were quantified using ImageJ software after normalization to total protein signals.</p></sec><sec id="Sec12"><title>Statistical analysis</title><p id="Par37">Data are represented as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD). Representative data are obtained from at least three independent experiments. Statistical analysis was conducted using a one-way analysis of variance (ANOVA) with a Tukey&#x02013;Kramer post-hoc test for multiple comparisons. Statistical significance was defined as <italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05</italic>.</p></sec></sec><sec id="Sec13"><title>Results</title><sec id="Sec14"><title>FPP suppresses IgE-mediated degranulation of RBL-2H3 rat basophilic leukemia cells</title><p id="Par38">A previous study has shown that oral FPP supplementation suppresses allergic rhinitis-like nasal symptoms in a murine model of Japanese cedar pollinosis, while allergen-specific IgE and T cell responses are unaffected upon feeding with FPP (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>). In this system, oral FPP supplementation down-regulates serum level of mouse mast cell protease-1 (mMCP-1), an in vivo biomarker of mast cell-mediated allergic inflammation (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>). This prompted us to assess the possibility that FPP acts on the mast cells to suppress immediate hypersensitivity reactions. To test this assumption, we first tested whether FPP suppressed IgE-mediated mast cell degranulation in vitro. We found that co-stimulation with FPP significantly suppressed DNP-BSA antigen (Ag)-driven &#x003b2;-hexosaminidase release from anti-DNP-IgE-sensitized RBL-2H3 rat basophilic leukemia cells in a dose-dependent manner (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). The IC<sub>50</sub> value for the degranulation inhibitory activity of water-soluble FPP fraction as 13.6&#x000a0;mg/ml. We also confirmed that the in vitro FPP stimulation did not show cytotoxicity against RBL-2H3 cells, as revealed by trypan blue dye exclusion assay (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>B). These results suggest that FPP acts directly on mast cells to suppress IgE-mediated degranulation.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>FPP suppresses IgE-mediated mast cell degranulation. <bold>A</bold>, Stimulation with FPP suppresses degranulation of RBL-2H3 cells. Degranulation was evaluated by the enzymatic activity of released &#x003b2;-hexosaminidase from IgE-sensitized RBL-2H3 cells upon pre-stimulation with a serial dose of FPP for 30&#x000a0;min, followed by stimulation with antigen (Ag; DNP-BSA) for 30&#x000a0;min. Ketotifen fumarate (KF, 500&#x000a0;&#x003bc;M) was used as a positive control for the inhibition of degranulation. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05</italic>; **<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.01 vs</italic> &#x0201c;IgE&#x02009;+&#x02009;Ag without FPP &#x0201c;. <bold>B</bold>, FPP has no inhibitory effect on the cell viability of IgE-sensitized RBL-2H3 cells. RBL-2H3 cells were cultured with a serial dose of FPP or KF for 30&#x000a0;min, and stimulation with Ag for 30&#x000a0;min. Cell viability was then analyzed by trypan blue dye exclusion assay</p></caption><graphic xlink:href="10616_2025_729_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec15"><title>Oral feeding with FPP suppresses in vivo immediate hypersensitivity reactions</title><p id="Par39">We next tested whether FPP also suppresses in vivo immediate hypersensitivity reaction by its oral feeding to a PCA model mouse. The oral FPP supplementation significantly suppressed PCA, as indicated by impaired extravasation of Evans blue dye in the IgE-sensitized ears (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>A and B). These results clearly indicate that FPP attenuates IgE and mast cell-mediated immediate hypersensitivity reactions in vivo.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Oral administration of FPP suppresses PCA. <bold>A</bold>, Representative photographs of the auricles in which PCA induction in the left ears was visualized by extravasation of Evans blue dye. lefts, intradermal (<italic>i.d.</italic>) sensitization with anti-DNP IgE mAb; rights, <italic>i.d.</italic> sensitization with PBS as a negative control. <bold>B</bold>, FPP supplementation significantly suppresses PCA. Extravasation of Evans blue dye was quantified by spectrophotometry. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05</italic></p></caption><graphic xlink:href="10616_2025_729_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec16"><title>FPP suppresses Fc&#x003b5;RI ligation-driven intracellular Ca<sup>2+</sup> influx and microtubule formation, both of which are essential for provoking IgE-mediated mast cell degranulation</title><p id="Par40">We next sought to elucidate mechanisms by which FPP suppresses immediate hypersensitivity reactions. The IgE-mediated mast cell degranulation is triggered through antigen-driven cross-linking of IgE, which is pre-sensitized on the mast cells via high-affinity IgE receptor, Fc&#x003b5;RI (Blank et al. <xref ref-type="bibr" rid="CR6">2021</xref>) (Kawakami and Galli <xref ref-type="bibr" rid="CR19">2002</xref>). The Fc&#x003b5;RI ligation activates two signaling events essential for mast cell degranulation; one is intracellular Ca<sup>2+</sup> influx needed for granule exocytosis (Nadler and Kinet <xref ref-type="bibr" rid="CR27">2002</xref>) (Blank and Rivera <xref ref-type="bibr" rid="CR5">2004</xref>) (Huber et al. <xref ref-type="bibr" rid="CR12">2019</xref>), and another is a Ca<sup>2+</sup>-independent microtubule formation that is critical for granule translocation to the plasma membrane (Nishida et al. <xref ref-type="bibr" rid="CR28">2005</xref>) (Ogawa et al. <xref ref-type="bibr" rid="CR30">2014</xref>). We first assessed whether FPP shows an inhibitory effect on those two Fc&#x003b5;RI signaling pathways in RBL-2H3 cells. We found that treatment with FPP significantly suppressed the Fc&#x003b5;RI ligation-driven intracellular Ca<sup>2+</sup> influx (as indicated by increased Fluo-4 Ca<sup>2+</sup> indicator signal) in a dose-dependent manner (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A). We also found that the FPP stimulation inhibited the Ca<sup>2+</sup>-independent microtubule formation upon Fc&#x003b5;RI ligation, as demonstrated by immunofluorescent staining of &#x003b1;-tubulin (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B). These results indicate that FPP suppresses Fc&#x003b5;RI ligation-driven intracellular Ca<sup>2+</sup> influx and microtubule formation, both of which are essential for IgE-mediated mast cell degranulation.<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>FPP suppresses Fc&#x003b5;RI-driven intracellular Ca<sup>2+</sup> influx and microtubule formation, both of which are essential for IgE-mediated degranulation of mast cells. <bold>A</bold>: Stimulation with FPP inhibits intracellular Ca<sup>2+</sup> influx. Ca<sup>2+</sup> influx was monitored using Fluo 4-AM, a Ca<sup>2+</sup>-sensitive fluorescence probe. Fluo 4-AM loaded, and IgE-sensitized RBL-2H3 cells were treated with a serial dose of FPP for 30&#x000a0;min, followed by stimulation with Ag (DNP-BSA), and then immediately subjected to time-course analysis of Ca<sup>2+</sup> mobilization. The vertical axis was represented as relative changes in Fluo-4 emission (F/F<sub>0</sub>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05 vs</italic> &#x0201c;Ag&#x0201d; (without FPP). <bold>B</bold>, FPP suppresses microtubule formation upon Fc&#x003b5;RI cross-linking. IgE-sensitized RBL-2H3 cells were pre-treated with 15&#x000a0;mg/ml FPP or 3&#x000a0;&#x003bc;M nocodazole (a microtubule inhibitor, as a positive control) for 30&#x000a0;min, followed by stimulation with Ag for 5&#x000a0;min. Then the cell samples were co-stained with Alexa Fluor 488-conjugated anti-&#x003b1;-tubulin mAb (green) and DAPI (blue). Immunofluorescence signal was visualized by confocal laser scanning microscopy. The scale bar shows 10&#x000a0;&#x003bc;m</p></caption><graphic xlink:href="10616_2025_729_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec17"><title>FPP extensively suppresses the Ca<sup>2+</sup>-dependent- and -independent Fc&#x003b5;RI signaling pathways</title><p id="Par41">We further analyzed detailed molecular mechanisms by which FPP negatively regulates the Fc&#x003b5;RI signaling pathways to suppress the degranulation of RBL-2H3 cells. To clarify the suppressive mechanisms of FPP on intracellular Ca<sup>2+</sup> influx, we tested the effect of FPP stimulation on the phosphorylation of Syk and PLC&#x003b3;1, upstream molecules of the Ca<sup>2+</sup>-dependent Fc&#x003b5;RI signaling pathway. We found that FPP stimulation seemed to inhibit the phosphorylation of Syk upon Fc&#x003b5;RI ligation, while phosphorylation of PLC&#x003b3;1 was unaffected (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A), suggesting that FPP acts on molecular events downstream of PLC&#x003b3;1 to suppress Ca<sup>2+</sup> influx. We next tested whether FPP inhibited the downstream store-operated calcium entry (SOCE) to suppress intracellular Ca<sup>2+</sup> influx. As shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B, FPP strikingly suppressed SOCE upon pharmacological treatment with thapsigargin, a&#x03000;sarcoplasmic/endoplasmic reticulum Ca<sup>2+</sup> ATPase (SERCA) inhibitor that induces SOCE via Ca<sup>2+</sup> depletion from the endoplasmic reticulum (ER) (Thastrup et al. <xref ref-type="bibr" rid="CR35">1990</xref>). Another pharmacological evidence further confirmed that FPP also suppressed the low-dose (0.9&#x000a0;&#x003bc;M) ionomycin-induced SOCE (Morgan and Jacob <xref ref-type="bibr" rid="CR26">1994</xref>) (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>C). These results suggest that FPP suppresses the Ca<sup>2+</sup>-dependent Fc&#x003b5;RI signaling pathway at least in part by down-regulation of the SOCE processes. We also explored the mechanisms by which FPP negatively regulates another Ca<sup>2+</sup>-independent Fc&#x003b5;RI signaling pathway (the PI3K-Akt-GSK-3&#x003b2; pathway), leading to microtubule formation (Ogawa et al. <xref ref-type="bibr" rid="CR30">2014</xref>). We found that FPP suppresses the Fc&#x003b5;RI ligation-driven phosphorylation of PI3K, Akt, and GSK-3&#x003b2; (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>). Taken together, these mechanistic analyses suggest that FPP extensively suppresses both the Ca<sup>2+</sup>-dependent- and -independent Fc&#x003b5;RI signaling pathways to inhibit immediate hypersensitivity reactions.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>FPP suppresses Ca<sup>2+</sup>-dependent Fc&#x003b5;RI signaling pathway. <bold>A</bold>, Effect of FPP on the activation of the Syk-PLC&#x003b3;1 axis upon Fc&#x003b5;RI cross-linking. IgE-sensitized RBL-2H3 cells were treated with 15&#x000a0;mg/ml FPP for 30&#x000a0;min, followed by Ag (DNP-BSA) stimulation for 1, 2, 5 and 10&#x000a0;min. Each cell lysate was subjected to immunoblot analysis with specific antibodies against Syk, PLC&#x003b3;1, or their phosphorylated forms. <bold>B</bold>, FPP inhibits thapsigargin (TG)-induced store-operated calcium entry (SOCE). Fluo 4-AM loaded RBL-2H3 cells were pre-treated with a serial dose of FPP for 30&#x000a0;min in Ca<sup>2+</sup>-free medium, and then stimulated with 10&#x000a0;&#x003bc;M TG. The cells were immediately subjected to a time-course analysis of Ca<sup>2+</sup> mobilization upon addition of TG. The vertical axis indicates relative changes in Fluo-4 emission (F/F<sub>0</sub>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05 vs</italic> &#x0201c;TG&#x0201d; (Thapsigargin without FPP). <bold>C</bold>, FPP inhibits ionomycin-induced SOCE. Fluo 4-AM loaded, and FPP-pre-treated RBL-2H3 cells were stimulated with 0.9&#x000a0;&#x003bc;M ionomycin. The vertical axis indicates relative changes in Fluo-4 emission (F/F<sub>0</sub>). *<italic>P</italic>&#x02009;&#x0003c;&#x02009;<italic>0.05 vs</italic> &#x0201c;iono&#x0201d; (ionomycin without FPP)</p></caption><graphic xlink:href="10616_2025_729_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig.&#x000a0;5</label><caption><p>FPP negatively regulates the Ca<sup>2+</sup>-independent Fc&#x003b5;RI signaling pathway. FPP suppresses activation of the PI3K-Akt-GSK3&#x003b2; axis upon Fc&#x003b5;RI cross-linking. IgE-sensitized RBL-2H3 cells were pre-treated with 15&#x000a0;mg/ml FPP for 30&#x000a0;min, followed by stimulation with Ag (DNP-BSA). Cell lysates were subjected to immunoblot analysis. An arrow indicates anti-phospho-PI3K-p85 (pPI3K-p85)-specific signals, and asterisk indicates non-specific bands</p></caption><graphic xlink:href="10616_2025_729_Fig5_HTML" id="MO5"/></fig></p></sec></sec><sec id="Sec18"><title>Discussion</title><p id="Par42">The previous study has shown that oral FPP supplementation prevents the development of allergic rhinitis-like nasal symptoms without affecting systemic immune response, suggesting that FPP may act on the IgE-mast cell axis to exert its anti-allergic effect (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>). Here, we provide evidence that FPP suppresses IgE-and mast cell-mediated type I hypersensitivity reactions in vitro as well as in vivo, and that the potent anti-allergic effect of FPP is fulfilled by extensive negative regulation of the Fc&#x003b5;RI signaling pathway.</p><p id="Par43">The canonical Fc&#x003b5;RI signaling branches into Ca<sup>2+</sup>-dependent, and Ca<sup>2+</sup>-independent pathways, and activation of both two pathways is critical for mast cell degranulation upon Fc&#x003b5;RI ligation (Nishida et al. <xref ref-type="bibr" rid="CR28">2005</xref>) (Ogawa et al. <xref ref-type="bibr" rid="CR30">2014</xref>). Our data indicate that FPP potently suppresses both two pathways, as evidenced by inhibition of Fc&#x003b5;RI-mediated intracellular Ca<sup>2+</sup> influx (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>A) and Ca<sup>2+</sup>-independent microtubule formation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>B). The dual inhibitory effect of FPP on both Ca<sup>2</sup>&#x0207a;-dependent and Ca<sup>2</sup>&#x0207a;-independent Fc&#x003b5;RI signaling provides a molecular basis for its potent anti-allergic activity, as evidenced by its oral administration significantly prevents immediate hypersensitivity reactions (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>) and Japanese cedar pollinosis (Fujimura et al. <xref ref-type="bibr" rid="CR10">2018</xref>). How does FPP negatively regulate these two pathways simultaneously? Especially in the Ca<sup>2+</sup>-independent pathway on which FPP fully suppresses the corresponding PI3K-Akt-GSK-3&#x003b2; signaling axis (shown in Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>), one possible upstream target of FPP could be Syk, whose activation (tyrosine phosphorylation) is suppressed upon stimulation with FPP (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A). In agreement with this assumption, Kitaura et al<italic>.</italic> (Kitaura et al. <xref ref-type="bibr" rid="CR23">2000</xref>) and Barbu et al<italic>.</italic> (Barbu et al. <xref ref-type="bibr" rid="CR3">2010</xref>) also have demonstrated that Syk works as a critical upstream activator of the PI3K-Akt pathway in mast cells.</p><p id="Par44">Our mechanistic analysis on the Ca<sup>2+</sup>-dependent Fc&#x003b5;RI signaling pathway revealed that FPP directly suppresses SOCE (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B and C) to inhibit intracellular Ca<sup>2+</sup> influx. Intriguingly, FPP not only inhibits SOCE provoked by a SERCA inhibitor thapsigargin (in the presence of Ca<sup>2+</sup> ions, as shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B), but also abolishes another thapsigargin-induced first Ca<sup>2+</sup> spike, a sign of Ca<sup>2+</sup> depletion from the ER (under Ca<sup>2+</sup>-free conditions, shown in Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B). This observation suggests that FPP antagonizes SERCA inhibitory activity of thapsigargin, which leads to impaired Ca<sup>2+</sup> depletion from the ER to suppress SOCE. In this scenario, the most plausible mechanism is that FPP may up-modulates Ca<sup>2+</sup> ATPase activity of SERCA to facilitate Ca<sup>2+</sup> entry into the ER (<italic>i.e.</italic>, suppression of Ca<sup>2+</sup> depletion from the ER), which in turn blocks downstream SOCE machinery to suppress intracellular Ca<sup>2+</sup> influx. Indeed, a recent pre-clinical trial indicates that activation of SERCA represents a new anti-allergic strategy to suppress IgE-mediated mast cell activation (Hunter et al. <xref ref-type="bibr" rid="CR13">2023</xref>). Further analysis is needed to see whether FPP activates SERCA to suppress Ca<sup>2+</sup> influx upon Fc&#x003b5;RI cross-linking. The potential SERCA activation capacity of FPP may provide a mechanistic explanation for how FPP suppresses the Ca<sup>2</sup>&#x0207a;-dependent Fc&#x003b5;RI signaling pathway while leaving upstream PLC&#x003b3;1 activity unaffected (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>A). The FPP-mediated inhibition of SOCE (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>B and C) through SERCA activation stabilizes ER Ca<sup>2</sup>&#x0207a; levels and inositol 1,4,5-trisphosphate (IP&#x02083;) receptor-dependent Ca<sup>2</sup>&#x0207a; influx. This sustained Ca<sup>2</sup>&#x0207a; signaling may enhance the Ca<sup>2</sup>&#x0207a;-dependent feedback activation of PLC&#x003b3;1 (Thore et al. <xref ref-type="bibr" rid="CR36">2005</xref>).</p><p id="Par45">The molecular nature of anti-allergic components in FPP needs further elucidation. Candidate active compounds could be pre-existing compounds from starter plant materials, or their fermented products. Another possible case is that those multiple compounds act synergistically to exert the mast cell-targeted anti-allergic action of FPP. Fruits and citrus contain abundant polyphenols that have been reported to show anti-allergic effects acting on mast cells (Debinska and Sozanska <xref ref-type="bibr" rid="CR8">2023</xref>). In fact, the most abundant starter materials for manufacturing FPP are fruits (<italic>e.g.</italic> apple, persimmon), and citrus accounts for 40.1% of total starter materials (Kawai <xref ref-type="bibr" rid="CR18">1994</xref>). Thus, those fruits-derived phytochemicals can be responsible for anti-allergic compounds in FPP. Another interesting study has demonstrated that sake lees (a byproduct of Japanese sake fermentation) fermented with lactic acid bacteria suppresses allergen-induced mast cell degranulation and allergic rhinitis-like nasal symptoms, while control unfermented sake lees starter fails to show such anti-allergic activity (Kawamoto et al. <xref ref-type="bibr" rid="CR20">2011</xref>). This suggests that de novo-synthesized compounds through fermentation, but not those from starter raw plant materials, can also be responsible for the anti-allergic effect of fermented sake lees. Our preliminary observations indicate that the anti-allergic components of FPP passed through the 10&#x000a0;kDa ultrafiltration filter (T. Kodama and S. Kawamoto, unpublished data). Further analysis is now underway to identify the active compounds in the FPP. The IC<sub>50</sub> value for the degranulation inhibitory activity of water-soluble FPP fraction as 13.6&#x000a0;mg/ml (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>A). We also tested the degranulation inhibitory activity of whole FPP containing insoluble fractions and found that the entire FPP potently suppressed the degranulation of RBL-2H3 cells with the IC<sub>50</sub> value of 11.4&#x000a0;mg/ml, which seems to be comparable to that of water-soluble FPP fraction (Kodama and Kawamoto, unpublished data). These data suggest that the soluble fraction of FPP mainly accounts for its anti-allergic potency, while insoluble components may also be involved in the in vivo PCA suppressive potency of dietary FPP containing insoluble ingredients.</p></sec><sec id="Sec19"><title>Conclusions</title><p id="Par46">In the present study, we show that FPP potently suppresses IgE- and mast cell-mediated immediate hypersensitivity reactions in vitro as well as in vivo. We also provide mechanistic evidence that FPP negatively regulates Fc&#x003b5;RI signaling pathway to suppress mast cell degranulation. The present study highlights the potential utility of dietary FPP supplementation in the prevention and/or attenuation of immediate hypersensitivity reactions targeting mast cell degranulation.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>FPP</term><def><p id="Par2">Fermented plant product</p></def></def-item><def-item><term>Th2</term><def><p id="Par3">T helper type 2</p></def></def-item><def-item><term>mMCP-1</term><def><p id="Par4">Mouse mast cell protease-1</p></def></def-item><def-item><term>MT Buffer</term><def><p id="Par5">Modified Tyrode&#x02019;s buffer</p></def></def-item><def-item><term>BSA</term><def><p id="Par6">Bovine serum albumin</p></def></def-item><def-item><term>MEM</term><def><p id="Par7">Minimum essential medium</p></def></def-item><def-item><term>FBS</term><def><p id="Par8">Fetal bovine serum</p></def></def-item><def-item><term>KF</term><def><p id="Par9">Ketotifen fumarate</p></def></def-item><def-item><term>Ag</term><def><p id="Par10">Antigen, PCA: Passive cutaneous anaphylaxis</p></def></def-item><def-item><term>HSA</term><def><p id="Par11">Human serum albumin</p></def></def-item><def-item><term>EB</term><def><p id="Par12">Evans blue</p></def></def-item><def-item><term>SOCE</term><def><p id="Par13">Store-operated Ca<sup>2+</sup> entry</p></def></def-item><def-item><term>EGTA</term><def><p id="Par14">Ethylene glycol tetraacetic acid</p></def></def-item><def-item><term>TG</term><def><p id="Par15">Thapsigargin</p></def></def-item><def-item><term>ER</term><def><p id="Par16">Endoplasmic reticulum</p></def></def-item><def-item><term>SDS-PAGE</term><def><p id="Par17">Sodium dodecyl sulfate&#x02013;polyacrylamide gel electrophoresis</p></def></def-item><def-item><term>PVDF</term><def><p id="Par18">Polyvinylidene fluoride</p></def></def-item><def-item><term>TBS</term><def><p id="Par19">Tris-buffered saline</p></def></def-item><def-item><term>SD</term><def><p id="Par20">Standard deviation</p></def></def-item><def-item><term>ANOVA</term><def><p id="Par21">Analysis of variance</p></def></def-item><def-item><term><italic>i.d.</italic></term><def><p id="Par22">Intradermal</p></def></def-item><def-item><term>SERCA</term><def><p id="Par23">Sarcoplasmic/endoplasmic reticulum Ca<sup>2+</sup> ATPase</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Tomoki Kodama, Ayana Yokoyama, and Yuki Nishioka have equally contributed to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We would like to thank Editage (<ext-link ext-link-type="uri" xlink:href="http://www.editage.jp">www.editage.jp</ext-link>) for English language editing.</p></ack><notes notes-type="author-contribution"><title><bold>Author contributions</bold></title><p>SK, TK, and AM: Conception and design of the study. TK, AY, YN, and RK: Data acquisition and analysis. All authors: Interpretation of data, drafting the article, and critical manuscript revision for important intellectual consent. All authors approved the submission and publication of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding provided by Hiroshima University. This work was financially supported by Manda Fermentation, Co., Ltd.</p></notes><notes notes-type="data-availability"><title>Data Availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par47">The authors declare that they have no conflict of interest.</p></notes><notes id="FPar2"><title>Ethical approval</title><p id="Par48">All animal experiments were carried out using protocols (protocol number: C20-2&#x02013;10) approved by the Committee on Animal Experimentation of Hiroshima University, Japan.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Akdis</surname><given-names>CA</given-names></name><name><surname>Akdis</surname><given-names>M</given-names></name></person-group><article-title>Mechanisms of allergen-specific immunotherapy</article-title><source>J Allergy Clin Immunol</source><year>2011</year><volume>127</volume><fpage>18</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2010.11.030</pub-id><pub-id pub-id-type="pmid">21211639</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Akdis CA, Akdis M (2011) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 127:18&#x02013;27. 10.1016/j.jaci.2010.11.030<pub-id pub-id-type="pmid">21211639</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Ashida</surname><given-names>T</given-names></name><name><surname>Okimasu</surname><given-names>E</given-names></name></person-group><article-title>Immunostimulatory effects of fermented vegetable product on the non-specific immunity of Japanese flounder Paralichthys olivaceus</article-title><source>Fish Sci</source><year>2005</year><volume>71</volume><fpage>257</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1111/j.1444-2906.2005.00958.x</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Ashida T, Okimasu E (2005) Immunostimulatory effects of fermented vegetable product on the non-specific immunity of Japanese flounder Paralichthys olivaceus. Fish Sci 71:257&#x02013;262</mixed-citation></citation-alternatives></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Barbu</surname><given-names>EA</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Siraganian</surname><given-names>RP</given-names></name></person-group><article-title>The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells</article-title><source>J Biol Chem</source><year>2010</year><volume>285</volume><fpage>15761</fpage><lpage>15768</lpage><pub-id pub-id-type="doi">10.1074/jbc.M110.109413</pub-id><pub-id pub-id-type="pmid">20335178</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Barbu EA, Zhang J, Siraganian RP (2010) The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells. J Biol Chem 285:15761&#x02013;15768. 10.1074/jbc.M110.109413<pub-id pub-id-type="pmid">20335178</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Baruah</surname><given-names>R</given-names></name><name><surname>Ray</surname><given-names>M</given-names></name><name><surname>Halami</surname><given-names>PM</given-names></name></person-group><article-title>Preventive and therapeutic aspects of fermented foods</article-title><source>J Appl Microbiol</source><year>2022</year><volume>132</volume><fpage>3476</fpage><lpage>3489</lpage><pub-id pub-id-type="doi">10.1111/jam.15444</pub-id><pub-id pub-id-type="pmid">35000256</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Baruah R, Ray M, Halami PM (2022) Preventive and therapeutic aspects of fermented foods. J Appl Microbiol 132:3476&#x02013;3489. 10.1111/jam.15444<pub-id pub-id-type="pmid">35000256</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>U</given-names></name><name><surname>Rivera</surname><given-names>J</given-names></name></person-group><article-title>The ins and outs of IgE-dependent mast-cell exocytosis</article-title><source>Trends Immunol</source><year>2004</year><volume>25</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1016/j.it.2004.03.005</pub-id><pub-id pub-id-type="pmid">15099567</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Blank U, Rivera J (2004) The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol 25:266&#x02013;273. 10.1016/j.it.2004.03.005<pub-id pub-id-type="pmid">15099567</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Blank</surname><given-names>U</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><article-title>The high affinity IgE receptor: a signaling update</article-title><source>Curr Opin Immunol</source><year>2021</year><volume>72</volume><fpage>51</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2021.03.015</pub-id><pub-id pub-id-type="pmid">33838574</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Blank U, Huang H, Kawakami T (2021) The high affinity IgE receptor: a signaling update. Curr Opin Immunol 72:51&#x02013;58. 10.1016/j.coi.2021.03.015<pub-id pub-id-type="pmid">33838574</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>HA</given-names></name><name><surname>Lin</surname><given-names>YS</given-names></name><name><surname>Tsao</surname><given-names>CW</given-names></name><name><surname>Shen</surname><given-names>MR</given-names></name><name><surname>Chiu</surname><given-names>WT</given-names></name></person-group><article-title>Differential Ca(2+) mobilization and mast cell degranulation by FcepsilonRI- and GPCR-mediated signaling</article-title><source>Cell Calcium</source><year>2017</year><volume>67</volume><fpage>31</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1016/j.ceca.2017.08.002</pub-id><pub-id pub-id-type="pmid">29029788</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Chen YC, Chang YC, Chang HA, Lin YS, Tsao CW, Shen MR, Chiu WT (2017) Differential Ca(2+) mobilization and mast cell degranulation by FcepsilonRI- and GPCR-mediated signaling. Cell Calcium 67:31&#x02013;39. 10.1016/j.ceca.2017.08.002<pub-id pub-id-type="pmid">29029788</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Debinska</surname><given-names>A</given-names></name><name><surname>Sozanska</surname><given-names>B</given-names></name></person-group><article-title>Dietary polyphenols-natural bioactive compounds with potential for preventing and treating some allergic conditions</article-title><source>Nutrients</source><year>2023</year><volume>15</volume><fpage>4823</fpage><pub-id pub-id-type="doi">10.3390/nu15224823</pub-id><pub-id pub-id-type="pmid">38004216</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Debinska A, Sozanska B (2023) Dietary polyphenols-natural bioactive compounds with potential for preventing and treating some allergic conditions. Nutrients 15:4823. 10.3390/nu15224823<pub-id pub-id-type="pmid">38004216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>T</given-names></name><name><surname>Kawamoto</surname><given-names>S</given-names></name></person-group><article-title>Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy</article-title><source>Allergol Int</source><year>2015</year><volume>64</volume><fpage>312</fpage><lpage>320</lpage><pub-id pub-id-type="doi">10.1016/j.alit.2015.05.008</pub-id><pub-id pub-id-type="pmid">26433527</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Fujimura T, Kawamoto S (2015) Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy. Allergol Int 64:312&#x02013;320. 10.1016/j.alit.2015.05.008<pub-id pub-id-type="pmid">26433527</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>T</given-names></name><name><surname>Hori</surname><given-names>A</given-names></name><name><surname>Torii</surname><given-names>H</given-names></name><name><surname>Kishida</surname><given-names>S</given-names></name><name><surname>Matsuura</surname><given-names>Y</given-names></name><name><surname>Kawamoto</surname><given-names>S</given-names></name></person-group><article-title>Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis</article-title><source>World Allergy Organ J</source><year>2018</year><volume>11</volume><fpage>31</fpage><pub-id pub-id-type="doi">10.1186/s40413-018-0213-4</pub-id><pub-id pub-id-type="pmid">30524645</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Fujimura T, Hori A, Torii H, Kishida S, Matsuura Y, Kawamoto S (2018) Intake of a fermented plant product attenuates allergic symptoms without changing systemic immune responses in a mouse model of Japanese cedar pollinosis. World Allergy Organ J 11:31. 10.1186/s40413-018-0213-4<pub-id pub-id-type="pmid">30524645</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Fujimura</surname><given-names>Y</given-names></name><name><surname>Yoshimoto</surname><given-names>T</given-names></name><name><surname>Fujino</surname><given-names>K</given-names></name><name><surname>Nezu</surname><given-names>A</given-names></name><name><surname>Marugame</surname><given-names>Y</given-names></name><name><surname>Bae</surname><given-names>J</given-names></name><name><surname>Kumazoe</surname><given-names>M</given-names></name><name><surname>Tachibana</surname><given-names>H</given-names></name></person-group><article-title>Bioactivity-boosting strategy based on combination of anti-allergic O-methylated catechin with a Citrus flavanone, hesperetin</article-title><source>J Nat Med</source><year>2023</year><volume>77</volume><fpage>363</fpage><lpage>369</lpage><pub-id pub-id-type="doi">10.1007/s11418-022-01668-5</pub-id><pub-id pub-id-type="pmid">36494586</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Fujimura Y, Yoshimoto T, Fujino K, Nezu A, Marugame Y, Bae J, Kumazoe M, Tachibana H (2023) Bioactivity-boosting strategy based on combination of anti-allergic O-methylated catechin with a Citrus flavanone, hesperetin. J Nat Med 77:363&#x02013;369. 10.1007/s11418-022-01668-5<pub-id pub-id-type="pmid">36494586</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>M</given-names></name><name><surname>Cato</surname><given-names>ACB</given-names></name><name><surname>Ainooson</surname><given-names>GK</given-names></name><name><surname>Freichel</surname><given-names>M</given-names></name><name><surname>Tsvilovskyy</surname><given-names>V</given-names></name><name><surname>Jessberger</surname><given-names>R</given-names></name><name><surname>Riedlinger</surname><given-names>E</given-names></name><name><surname>Sommerhoff</surname><given-names>CP</given-names></name><name><surname>Bischoff</surname><given-names>SC</given-names></name></person-group><article-title>Regulation of the pleiotropic effects of tissue-resident mast cells</article-title><source>J Allergy Clin Immunol</source><year>2019</year><volume>144</volume><fpage>S31</fpage><lpage>S45</lpage><pub-id pub-id-type="doi">10.1016/j.jaci.2019.02.004</pub-id><pub-id pub-id-type="pmid">30772496</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Huber M, Cato ACB, Ainooson GK, Freichel M, Tsvilovskyy V, Jessberger R, Riedlinger E, Sommerhoff CP, Bischoff SC (2019) Regulation of the pleiotropic effects of tissue-resident mast cells. J Allergy Clin Immunol 144:S31&#x02013;S45. 10.1016/j.jaci.2019.02.004<pub-id pub-id-type="pmid">30772496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>KD</given-names></name><name><surname>Crozier</surname><given-names>RWE</given-names></name><name><surname>Braun</surname><given-names>JL</given-names></name><name><surname>Fajardo</surname><given-names>VA</given-names></name><name><surname>MacNeil</surname><given-names>AJ</given-names></name></person-group><article-title>Acute activation of SERCA with CDN1163 attenuates IgE-mediated mast cell activation through selective impairment of ROS and p38 signaling</article-title><source>FASEB J</source><year>2023</year><volume>37</volume><fpage>e22748</fpage><pub-id pub-id-type="doi">10.1096/fj.202201272R</pub-id><pub-id pub-id-type="pmid">36624659</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Hunter KD, Crozier RWE, Braun JL, Fajardo VA, MacNeil AJ (2023) Acute activation of SERCA with CDN1163 attenuates IgE-mediated mast cell activation through selective impairment of ROS and p38 signaling. FASEB J 37:e22748. 10.1096/fj.202201272R<pub-id pub-id-type="pmid">36624659</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Kamei</surname><given-names>R</given-names></name><name><surname>Fujimura</surname><given-names>T</given-names></name><name><surname>Matsuda</surname><given-names>M</given-names></name><name><surname>Kakihara</surname><given-names>K</given-names></name><name><surname>Hirakawa</surname><given-names>N</given-names></name><name><surname>Baba</surname><given-names>K</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name><name><surname>Arakawa</surname><given-names>K</given-names></name><name><surname>Kawamoto</surname><given-names>S</given-names></name></person-group><article-title>A flavanone derivative from the Asian medicinal herb (Perilla frutescens) potently suppresses IgE-mediated immediate hypersensitivity reactions</article-title><source>Biochem Biophys Res Commun</source><year>2017</year><volume>483</volume><fpage>674</fpage><lpage>679</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.12.083</pub-id><pub-id pub-id-type="pmid">27986566</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Kamei R, Fujimura T, Matsuda M, Kakihara K, Hirakawa N, Baba K, Ono K, Arakawa K, Kawamoto S (2017) A flavanone derivative from the Asian medicinal herb (Perilla frutescens) potently suppresses IgE-mediated immediate hypersensitivity reactions. Biochem Biophys Res Commun 483:674&#x02013;679. 10.1016/j.bbrc.2016.12.083<pub-id pub-id-type="pmid">27986566</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Karakus</surname><given-names>E</given-names></name><name><surname>Wannowius</surname><given-names>M</given-names></name><name><surname>Muller</surname><given-names>SF</given-names></name><name><surname>Leiting</surname><given-names>S</given-names></name><name><surname>Leidolf</surname><given-names>R</given-names></name><name><surname>Noppes</surname><given-names>S</given-names></name><name><surname>Oswald</surname><given-names>S</given-names></name><name><surname>Diener</surname><given-names>M</given-names></name><name><surname>Geyer</surname><given-names>J</given-names></name></person-group><article-title>The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling</article-title><source>Sci Rep</source><year>2020</year><volume>10</volume><fpage>7248</fpage><pub-id pub-id-type="doi">10.1038/s41598-020-64006-3</pub-id><pub-id pub-id-type="pmid">32350310</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Karakus E, Wannowius M, Muller SF, Leiting S, Leidolf R, Noppes S, Oswald S, Diener M, Geyer J (2020) The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling. Sci Rep 10:7248. 10.1038/s41598-020-64006-3<pub-id pub-id-type="pmid">32350310</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Matsuura</surname><given-names>S</given-names></name></person-group><article-title>Manda suppresses emotional stress-induced stomach ulcers in rats</article-title><source>Int J Stress Manage</source><year>1997</year><volume>4</volume><fpage>63</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1007/BF02766073</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Kawai M, Matsuura S (1997) Manda suppresses emotional stress-induced stomach ulcers in rats. Int J Stress Manage 4:63&#x02013;69</mixed-citation></citation-alternatives></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Matsuura</surname><given-names>S</given-names></name><name><surname>Asanuma</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>N</given-names></name></person-group><article-title>Manda, a fermented natural food, suppresses lipid peroxidation in the senescent rat brain</article-title><source>Neurochem Res</source><year>1998</year><volume>23</volume><fpage>455</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1023/a:1022475830587</pub-id><pub-id pub-id-type="pmid">9566578</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Kawai M, Matsuura S, Asanuma M, Ogawa N (1998) Manda, a fermented natural food, suppresses lipid peroxidation in the senescent rat brain. Neurochem Res 23:455&#x02013;461. 10.1023/a:1022475830587<pub-id pub-id-type="pmid">9566578</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><mixed-citation publication-type="other">Kawai M, Matsuura S, Mori, A. (1994) Free radical scavenging action of MANDA. Clin Rep. 28: 393-397 (in Japanese).</mixed-citation></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>T</given-names></name><name><surname>Galli</surname><given-names>SJ</given-names></name></person-group><article-title>Regulation of mast-cell and basophil function and survival by IgE</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>773</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1038/nri914</pub-id><pub-id pub-id-type="pmid">12360215</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Kawakami T, Galli SJ (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2:773&#x02013;786. 10.1038/nri914<pub-id pub-id-type="pmid">12360215</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>S</given-names></name><name><surname>Kaneoke</surname><given-names>M</given-names></name><name><surname>Ohkouchi</surname><given-names>K</given-names></name><name><surname>Amano</surname><given-names>Y</given-names></name><name><surname>Takaoka</surname><given-names>Y</given-names></name><name><surname>Kume</surname><given-names>K</given-names></name><name><surname>Aki</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Kadowaki</surname><given-names>M</given-names></name><name><surname>Hirata</surname><given-names>D</given-names></name><name><surname>Ono</surname><given-names>K</given-names></name></person-group><article-title>Sake lees fermented with lactic acid bacteria prevents allergic rhinitis-like symptoms and IgE-mediated basophil degranulation</article-title><source>Biosci Biotechnol Biochem</source><year>2011</year><volume>75</volume><fpage>140</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1271/bbb.100541</pub-id><pub-id pub-id-type="pmid">21228477</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Kawamoto S, Kaneoke M, Ohkouchi K, Amano Y, Takaoka Y, Kume K, Aki T, Yamashita S, Watanabe K, Kadowaki M, Hirata D, Ono K (2011) Sake lees fermented with lactic acid bacteria prevents allergic rhinitis-like symptoms and IgE-mediated basophil degranulation. Biosci Biotechnol Biochem 75:140&#x02013;144. 10.1271/bbb.100541<pub-id pub-id-type="pmid">21228477</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>R</given-names></name><name><surname>Kawamura</surname><given-names>S</given-names></name><name><surname>Kodama</surname><given-names>T</given-names></name><name><surname>Yamana</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>A</given-names></name><name><surname>Yimiti</surname><given-names>D</given-names></name><name><surname>Miyaki</surname><given-names>S</given-names></name><name><surname>Hino</surname><given-names>S</given-names></name><name><surname>Ozawa</surname><given-names>N</given-names></name><name><surname>Nishimura</surname><given-names>T</given-names></name><name><surname>Kawamoto</surname><given-names>S</given-names></name><name><surname>Ikeda</surname><given-names>A</given-names></name></person-group><article-title>Development of a water-dispersible supramolecular complex of polyphenol with polypeptides for attenuation of the allergic response using a mechanochemical strategy</article-title><source>Macromol Biosci</source><year>2023</year><volume>23</volume><fpage>e2200462</fpage><pub-id pub-id-type="doi">10.1002/mabi.202200462</pub-id><pub-id pub-id-type="pmid">36640295</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Kawasaki R, Kawamura S, Kodama T, Yamana K, Maeda A, Yimiti D, Miyaki S, Hino S, Ozawa N, Nishimura T, Kawamoto S, Ikeda A (2023) Development of a water-dispersible supramolecular complex of polyphenol with polypeptides for attenuation of the allergic response using a mechanochemical strategy. Macromol Biosci 23:e2200462. 10.1002/mabi.202200462<pub-id pub-id-type="pmid">36640295</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Kay</surname><given-names>GG</given-names></name></person-group><article-title>The effects of antihistamines on cognition and performance</article-title><source>J Allergy Clin Immunol</source><year>2000</year><volume>105</volume><fpage>S622</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1067/mai.2000.106153</pub-id><pub-id pub-id-type="pmid">10856168</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Kay GG (2000) The effects of antihistamines on cognition and performance. J Allergy Clin Immunol 105:S622-627. 10.1067/mai.2000.106153<pub-id pub-id-type="pmid">10856168</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Kitaura</surname><given-names>J</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Maeda-Yamamoto</surname><given-names>M</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Kikkawa</surname><given-names>U</given-names></name><name><surname>Kawakami</surname><given-names>T</given-names></name></person-group><article-title>Akt-dependent cytokine production in mast cells</article-title><source>J Exp Med</source><year>2000</year><volume>192</volume><fpage>729</fpage><lpage>740</lpage><pub-id pub-id-type="doi">10.1084/jem.192.5.729</pub-id><pub-id pub-id-type="pmid">10974038</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Kitaura J, Asai K, Maeda-Yamamoto M, Kawakami Y, Kikkawa U, Kawakami T (2000) Akt-dependent cytokine production in mast cells. J Exp Med 192:729&#x02013;740. 10.1084/jem.192.5.729<pub-id pub-id-type="pmid">10974038</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Malone M</surname><given-names>M</given-names></name><name><surname>Kennedy</surname><given-names>TM</given-names></name></person-group><article-title>Review: side effects of some commonly used allergy medications (decongestants, anti-leukotriene agents, antihistamines, steroids, and zinc) and their safety in pregnancy</article-title><source>Int J Allergy Medicat</source><year>2017</year><volume>3</volume><fpage>024</fpage><pub-id pub-id-type="doi">10.23937/2572-3308.1510024</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Malone M, Kennedy TM (2017) Review: side effects of some commonly used allergy medications (decongestants, anti-leukotriene agents, antihistamines, steroids, and zinc) and their safety in pregnancy. Int J Allergy Medicat 3:024. 10.23937/2572-3308.1510024</mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Marotta</surname><given-names>F</given-names></name><name><surname>Yadav</surname><given-names>H</given-names></name><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Minelli</surname><given-names>E</given-names></name><name><surname>Signorelli</surname><given-names>P</given-names></name><name><surname>Lorenzetti</surname><given-names>A</given-names></name><name><surname>Marandola</surname><given-names>P</given-names></name></person-group><article-title>Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical: an in vitro and in vivo study</article-title><source>Ann N Y Acad Sci</source><year>2009</year><volume>1155</volume><fpage>273</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1111/j.1749-6632.2008.03684.x</pub-id><pub-id pub-id-type="pmid">19250216</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Marotta F, Yadav H, Pathak S, Minelli E, Signorelli P, Lorenzetti A, Marandola P (2009) Inhibition of human breast cancer cell growth and enzymatic activity by a fermented nutraceutical: an in vitro and in vivo study. Ann N Y Acad Sci 1155:273&#x02013;277. 10.1111/j.1749-6632.2008.03684.x<pub-id pub-id-type="pmid">19250216</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>AJ</given-names></name><name><surname>Jacob</surname><given-names>R</given-names></name></person-group><article-title>Ionomycin enhances Ca<sup>2+</sup> influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane</article-title><source>Biochem J</source><year>1994</year><volume>300</volume><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1042/bj3000665</pub-id><pub-id pub-id-type="pmid">8010948</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Morgan AJ, Jacob R (1994) Ionomycin enhances Ca<sup>2+</sup> influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane. Biochem J 300:665&#x02013;672. 10.1042/bj3000665<pub-id pub-id-type="pmid">8010948</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Nadler</surname><given-names>MJ</given-names></name><name><surname>Kinet</surname><given-names>JP</given-names></name></person-group><article-title>Uncovering new complexities in mast cell signaling</article-title><source>Nat Immunol</source><year>2002</year><volume>3</volume><fpage>707</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1038/ni0802-707</pub-id><pub-id pub-id-type="pmid">12145654</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Nadler MJ, Kinet JP (2002) Uncovering new complexities in mast cell signaling. Nat Immunol 3:707&#x02013;708. 10.1038/ni0802-707<pub-id pub-id-type="pmid">12145654</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>K</given-names></name><name><surname>Yamasaki</surname><given-names>S</given-names></name><name><surname>Ito</surname><given-names>Y</given-names></name><name><surname>Kabu</surname><given-names>K</given-names></name><name><surname>Hattori</surname><given-names>K</given-names></name><name><surname>Tezuka</surname><given-names>T</given-names></name><name><surname>Nishizumi</surname><given-names>H</given-names></name><name><surname>Kitamura</surname><given-names>D</given-names></name><name><surname>Goitsuka</surname><given-names>R</given-names></name><name><surname>Geha</surname><given-names>RS</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Yagi</surname><given-names>T</given-names></name><name><surname>Hirano</surname><given-names>T</given-names></name></person-group><article-title>Fc&#x003b5;RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane</article-title><source>J Cell Biol</source><year>2005</year><volume>170</volume><fpage>115</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1083/jcb.200501111</pub-id><pub-id pub-id-type="pmid">15998803</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Nishida K, Yamasaki S, Ito Y, Kabu K, Hattori K, Tezuka T, Nishizumi H, Kitamura D, Goitsuka R, Geha RS, Yamamoto T, Yagi T, Hirano T (2005) Fc&#x003b5;RI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol 170:115&#x02013;126. 10.1083/jcb.200501111<pub-id pub-id-type="pmid">15998803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Nugrahini</surname><given-names>AD</given-names></name><name><surname>Ishida</surname><given-names>M</given-names></name><name><surname>Nakagawa</surname><given-names>T</given-names></name><name><surname>Nishi</surname><given-names>K</given-names></name><name><surname>Sugahara</surname><given-names>T</given-names></name></person-group><article-title>Trigonelline: An alkaloid with anti-degranulation properties</article-title><source>Mol Immunol</source><year>2020</year><volume>118</volume><fpage>201</fpage><lpage>209</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2019.12.020</pub-id><pub-id pub-id-type="pmid">31896496</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Nugrahini AD, Ishida M, Nakagawa T, Nishi K, Sugahara T (2020) Trigonelline: An alkaloid with anti-degranulation properties. Mol Immunol 118:201&#x02013;209. 10.1016/j.molimm.2019.12.020<pub-id pub-id-type="pmid">31896496</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Tanaka</surname><given-names>Y</given-names></name><name><surname>Uruno</surname><given-names>T</given-names></name><name><surname>Duan</surname><given-names>X</given-names></name><name><surname>Harada</surname><given-names>Y</given-names></name><name><surname>Sanematsu</surname><given-names>F</given-names></name><name><surname>Yamamura</surname><given-names>K</given-names></name><name><surname>Terasawa</surname><given-names>M</given-names></name><name><surname>Nishikimi</surname><given-names>A</given-names></name><name><surname>Cote</surname><given-names>JF</given-names></name><name><surname>Fukui</surname><given-names>Y</given-names></name></person-group><article-title>DOCK5 functions as a key signaling adaptor that links FcepsilonRI signals to microtubule dynamics during mast cell degranulation</article-title><source>J Exp Med</source><year>2014</year><volume>211</volume><fpage>1407</fpage><lpage>1419</lpage><pub-id pub-id-type="doi">10.1084/jem.20131926</pub-id><pub-id pub-id-type="pmid">24913231</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Ogawa K, Tanaka Y, Uruno T, Duan X, Harada Y, Sanematsu F, Yamamura K, Terasawa M, Nishikimi A, Cote JF, Fukui Y (2014) DOCK5 functions as a key signaling adaptor that links FcepsilonRI signals to microtubule dynamics during mast cell degranulation. J Exp Med 211:1407&#x02013;1419. 10.1084/jem.20131926<pub-id pub-id-type="pmid">24913231</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>HA</given-names></name><name><surname>Park</surname><given-names>CS</given-names></name><name><surname>Ahn</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>YS</given-names></name><name><surname>Kim</surname><given-names>HM</given-names></name></person-group><article-title>Effect of Perilla frutescens var. acuta Kudo and rosmarinic acid on allergic inflammatory reactions</article-title><source>Exp Biol Med (Maywood)</source><year>2011</year><volume>236</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1258/ebm.2010.010252</pub-id><pub-id pub-id-type="pmid">21239739</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Oh HA, Park CS, Ahn HJ, Park YS, Kim HM (2011) Effect of Perilla frutescens var. acuta Kudo and rosmarinic acid on allergic inflammatory reactions. Exp Biol Med (Maywood) 236:99&#x02013;106. 10.1258/ebm.2010.010252<pub-id pub-id-type="pmid">21239739</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Rajan</surname><given-names>TV</given-names></name></person-group><article-title>The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation</article-title><source>Trends Immunol</source><year>2003</year><volume>24</volume><fpage>376</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1016/s1471-4906(03)00142-x</pub-id><pub-id pub-id-type="pmid">12860528</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Rajan TV (2003) The Gell-Coombs classification of hypersensitivity reactions: a re-interpretation. Trends Immunol 24:376&#x02013;379. 10.1016/s1471-4906(03)00142-x<pub-id pub-id-type="pmid">12860528</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanlier</surname><given-names>N</given-names></name><name><surname>Gokcen</surname><given-names>BB</given-names></name><name><surname>Sezgin</surname><given-names>AC</given-names></name></person-group><article-title>Health benefits of fermented foods</article-title><source>Crit Rev Food Sci Nutr</source><year>2019</year><volume>59</volume><fpage>506</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1080/10408398.2017.1383355</pub-id><pub-id pub-id-type="pmid">28945458</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Sanlier N, Gokcen BB, Sezgin AC (2019) Health benefits of fermented foods. Crit Rev Food Sci Nutr 59:506&#x02013;527. 10.1080/10408398.2017.1383355<pub-id pub-id-type="pmid">28945458</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Shahbazi</surname><given-names>R</given-names></name><name><surname>Sharifzad</surname><given-names>F</given-names></name><name><surname>Bagheri</surname><given-names>R</given-names></name><name><surname>Alsadi</surname><given-names>N</given-names></name><name><surname>Yasavoli-Sharahi</surname><given-names>H</given-names></name><name><surname>Matar</surname><given-names>C</given-names></name></person-group><article-title>Anti-inflammatory and immunomodulatory properties of fermented plant foods</article-title><source>Nutrients</source><year>2021</year><pub-id pub-id-type="doi">10.3390/nu13051516</pub-id><pub-id pub-id-type="pmid">33946303</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Shahbazi R, Sharifzad F, Bagheri R, Alsadi N, Yasavoli-Sharahi H, Matar C (2021) Anti-inflammatory and immunomodulatory properties of fermented plant foods. Nutrients. 10.3390/nu13051516<pub-id pub-id-type="pmid">33946303</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Thastrup</surname><given-names>O</given-names></name><name><surname>Cullen</surname><given-names>PJ</given-names></name><name><surname>Drobak</surname><given-names>BK</given-names></name><name><surname>Hanley</surname><given-names>MR</given-names></name><name><surname>Dawson</surname><given-names>AP</given-names></name></person-group><article-title>Thapsigargin, a tumor promoter, discharges intracellular Ca<sup>2+</sup> stores by specific inhibition of the endoplasmic reticulum Ca<sup>2+</sup>-ATPase</article-title><source>Proc Natl Acad Sci U S A</source><year>1990</year><volume>87</volume><fpage>2466</fpage><lpage>2470</lpage><pub-id pub-id-type="doi">10.1073/pnas.87.7.2466</pub-id><pub-id pub-id-type="pmid">2138778</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Thastrup O, Cullen PJ, Drobak BK, Hanley MR, Dawson AP (1990) Thapsigargin, a tumor promoter, discharges intracellular Ca<sup>2+</sup> stores by specific inhibition of the endoplasmic reticulum Ca<sup>2+</sup>-ATPase. Proc Natl Acad Sci U S A 87:2466&#x02013;2470. 10.1073/pnas.87.7.2466<pub-id pub-id-type="pmid">2138778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Thore</surname><given-names>S</given-names></name><name><surname>Dyachok</surname><given-names>O</given-names></name><name><surname>Gylfe</surname><given-names>E</given-names></name><name><surname>Tengholm</surname><given-names>A</given-names></name></person-group><article-title>Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca<sup>2+</sup> in insulin-secreting beta-cells</article-title><source>J Cell Sci</source><year>2005</year><volume>118</volume><fpage>4463</fpage><lpage>4471</lpage><pub-id pub-id-type="doi">10.1242/jcs.02577</pub-id><pub-id pub-id-type="pmid">16159958</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Thore S, Dyachok O, Gylfe E, Tengholm A (2005) Feedback activation of phospholipase C via intracellular mobilization and store-operated influx of Ca<sup>2+</sup> in insulin-secreting beta-cells. J Cell Sci 118:4463&#x02013;4471. 10.1242/jcs.02577<pub-id pub-id-type="pmid">16159958</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Weinberg</surname><given-names>EG</given-names></name></person-group><article-title>The WAO White Book on Allergy 2011&#x02013;2012</article-title><source>Current Allergy &#x00026; Clin Immunol</source><year>2011</year><volume>24</volume><fpage>156</fpage><lpage>157</lpage></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Weinberg EG (2011) The WAO White Book on Allergy 2011&#x02013;2012. Current Allergy &#x00026; Clin Immunol 24:156&#x02013;157</mixed-citation></citation-alternatives></ref><ref id="CR38"><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Guo</surname><given-names>M</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name></person-group><article-title>Perilla frutescens: a traditional medicine and food homologous plant</article-title><source>Chin Herb Med</source><year>2023</year><volume>15</volume><fpage>369</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1016/j.chmed.2023.03.002</pub-id><pub-id pub-id-type="pmid">37538863</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Wu X, Dong S, Chen H, Guo M, Sun Z, Luo H (2023) Perilla frutescens: a traditional medicine and food homologous plant. Chin Herb Med 15:369&#x02013;375. 10.1016/j.chmed.2023.03.002<pub-id pub-id-type="pmid">37538863</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Javeed</surname><given-names>A</given-names></name><name><surname>Jian</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>B</given-names></name></person-group><article-title>Treatment of allergy: Overview of synthetic anti-allergy small molecules in medicinal chemistry</article-title><source>Eur J Med Chem</source><year>2023</year><volume>249</volume><fpage>115151</fpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2023.115151</pub-id><pub-id pub-id-type="pmid">36731273</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Zhang S, Liu Y, Javeed A, Jian C, Sun J, Wu S, Han B (2023) Treatment of allergy: Overview of synthetic anti-allergy small molecules in medicinal chemistry. Eur J Med Chem 249:115151. 10.1016/j.ejmech.2023.115151<pub-id pub-id-type="pmid">36731273</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>